These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2883814)

  • 21. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial.
    Tollefson GD; Beasley CM; Tran PV; Street JS; Krueger JA; Tamura RN; Graffeo KA; Thieme ME
    Am J Psychiatry; 1997 Apr; 154(4):457-65. PubMed ID: 9090331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CT scans and neuroleptic response in schizophrenia: a multidimensional approach.
    Gattaz WF; Rost W; Kohlmeyer K; Bauer K; Hübner C; Gasser T
    Psychiatry Res; 1988 Dec; 26(3):293-303. PubMed ID: 3222394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of neuroleptics on platelet monoamine oxidase activity.
    Ho BT; Smith RC; Kralik P; Allen R; Schoolar J; Khan M; DeJohn C
    Biol Psychiatry; 1982 Aug; 17(8):885-95. PubMed ID: 6126230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics doses.
    de Bartolomeis A; Balletta R; Giordano S; Buonaguro EF; Latte G; Iasevoli F
    Psychiatry Res; 2013 Dec; 210(2):387-95. PubMed ID: 23910239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between brain structure and function in disorders of the schizophrenic spectrum: single positron emission computerized tomography, computerized tomography and psychopathology of first episodes.
    Rubin P; Hemmingsen R; Holm S; Møller-Madsen S; Hertel C; Povlsen UJ; Karle A
    Acta Psychiatr Scand; 1994 Oct; 90(4):281-9. PubMed ID: 7831999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First-episode neuroleptic-free schizophrenics: concentrations of monoamines and their metabolites in plasma and their correlations with clinical responses to haloperidol treatment.
    Nagaoka S; Iwamoto N; Arai H
    Biol Psychiatry; 1997 Apr; 41(8):857-64. PubMed ID: 9099412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EEG-brain mapping in schizophrenics with predominantly positive and negative symptoms. Comparative studies with remoxipride/haloperidol.
    Saletu B; Küfferle B; Anderer P; Grünberger J; Steinberger K
    Eur Neuropsychopharmacol; 1990 Nov; 1(1):27-36. PubMed ID: 1983779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.
    Krakowski MI; Czobor P; Citrome L; Bark N; Cooper TB
    Arch Gen Psychiatry; 2006 Jun; 63(6):622-9. PubMed ID: 16754835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MRI correlates of treatment response in first episode psychosis.
    Zipursky RB; Zhang-Wong J; Lambe EK; Bean G; Beiser M
    Schizophr Res; 1998 Feb; 30(1):81-90. PubMed ID: 9542791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cortical morphology of adolescents with bipolar disorder and with schizophrenia.
    Janssen J; Alemán-Gómez Y; Schnack H; Balaban E; Pina-Camacho L; Alfaro-Almagro F; Castro-Fornieles J; Otero S; Baeza I; Moreno D; Bargalló N; Parellada M; Arango C; Desco M
    Schizophr Res; 2014 Sep; 158(1-3):91-9. PubMed ID: 25085384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroleptic effects on serine and glycine metabolism.
    Baruah S; Waziri R; Sherman A
    Biol Psychiatry; 1993 Oct; 34(8):544-50. PubMed ID: 7903868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Empirical evaluation of the factorial structure of clinical symptoms in schizophrenia: effects of typical neuroleptics on the brief psychiatric rating scale.
    Harvey PD; Davidson M; White L; Keefe RS; Hirschowitz J; Mohs RC; Davis KL
    Biol Psychiatry; 1996 Oct; 40(8):755-60. PubMed ID: 8894068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical correlates of body weight changes in schizophrenia.
    Lawson WB; Karson CN
    J Neuropsychiatry Clin Neurosci; 1994; 6(2):187-8. PubMed ID: 8044044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders.
    Perkins D; Lieberman J; Gu H; Tohen M; McEvoy J; Green A; Zipursky R; Strakowski S; Sharma T; Kahn R; Gur R; Tollefson G;
    Br J Psychiatry; 2004 Jul; 185():18-24. PubMed ID: 15231551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computed tomography in schizophreniform disorder and other acute psychiatric disorders.
    Weinberger DR; DeLisi LE; Perman GP; Targum S; Wyatt RJ
    Arch Gen Psychiatry; 1982 Jul; 39(7):778-83. PubMed ID: 6984643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of clozapine, olanzapine, risperidone, and haloperidol in schizophrenia and schizoaffective disorder assessed with nurses observation scale for inpatient evaluation.
    Volavka J; Nolan KA; Kline L; Czobor P; Citrome L; Sheitman B; Lindenmayer JP; McEvoy J; Lieberman JA
    Schizophr Res; 2005 Jul; 76(1):127-9. PubMed ID: 15927808
    [No Abstract]   [Full Text] [Related]  

  • 37. Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group.
    Zimbroff DL; Kane JM; Tamminga CA; Daniel DG; Mack RJ; Wozniak PJ; Sebree TB; Wallin BA; Kashkin KB
    Am J Psychiatry; 1997 Jun; 154(6):782-91. PubMed ID: 9167505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Schizophrenic symptoms and deterioration. Relation to computed tomographic findings.
    Pandurangi AK; Bilder RM; Rieder RO; Mukherjee S; Hamer RM
    J Nerv Ment Dis; 1988 Apr; 176(4):200-6. PubMed ID: 3351498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comprehensive study of chronic schizophrenic patients. I. Quantitative computed tomography: cerebral density, ventricle and sulcal measures.
    Dewan MJ; Pandurangi AK; Lee SH; Ramachandran T; Levy B; Boucher M; Yozawitz A; Major L
    Acta Psychiatr Scand; 1986 Feb; 73(2):152-60. PubMed ID: 3705992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Volume increases in putamen associated with positive symptom reduction in previously drug-naive schizophrenia after 6 weeks antipsychotic treatment.
    Li M; Chen Z; Deng W; He Z; Wang Q; Jiang L; Ma X; Wang Y; Chua SE; Cheung C; McAlonan GM; Sham PC; Collier DA; Gong Q; Li T
    Psychol Med; 2012 Jul; 42(7):1475-83. PubMed ID: 22030695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.